Consumer Safety Act of 1972: Hearings, Ninety-second Congress, Second Session, on Titles I and II of S. 3419U.S. Government Printing Office, 1972 - 912 lappuses |
No grāmatas satura
1.–5. rezultāts no 100.
30. lappuse
... vaccine substrates where my first- hand experiences extend over the last decade . The production of human virus vaccines has historically depended upon advancements in the field of tissue or cell culture . Virus vaccines consist of ...
... vaccine substrates where my first- hand experiences extend over the last decade . The production of human virus vaccines has historically depended upon advancements in the field of tissue or cell culture . Virus vaccines consist of ...
31. lappuse
... vaccine virus substrates . This cannot be done with primary cells . 2. Enough vaccine can be produced from the cells ... VACCINES From the time that polio vaccines were first 31.
... vaccine virus substrates . This cannot be done with primary cells . 2. Enough vaccine can be produced from the cells ... VACCINES From the time that polio vaccines were first 31.
32. lappuse
... vaccine and an adenovirus vaccine administered to over a million people in the coun- try . This virus , SV 40 , produces tumors in rodents and can convert cultured normal human cells to cells with cancerlike properties . De- spite this ...
... vaccine and an adenovirus vaccine administered to over a million people in the coun- try . This virus , SV 40 , produces tumors in rodents and can convert cultured normal human cells to cells with cancerlike properties . De- spite this ...
33. lappuse
... vaccine to nearly 1 million recruits . Even today , other types of adenovirus vaccines prepared in WI - 38 are under development by the military . Why has DBS resisted encouraging the development of vaccines produced in normal human ...
... vaccine to nearly 1 million recruits . Even today , other types of adenovirus vaccines prepared in WI - 38 are under development by the military . Why has DBS resisted encouraging the development of vaccines produced in normal human ...
120. lappuse
... vaccine development . It will be my purpose to make three salient points from which I intend to draw five important conclusions . The points to be made are as follows : 1. That the DBS has been inordinately slow to respond to new ...
... vaccine development . It will be my purpose to make three salient points from which I intend to draw five important conclusions . The points to be made are as follows : 1. That the DBS has been inordinately slow to respond to new ...
Bieži izmantoti vārdi un frāzes
action activities adenovirus adenovirus vaccines animals Anthony Morris antibody antigen antisera authority bill biological products Biologics Standards blood banks budget CCA test cell cultures Commissioner committee Congress consumer product safety Consumer Safety Agency containing Cosmetic Act cyclamates Department Director disease Division of Biologics Drug Administration Eddy effective efficacy enforcement established evaluation FDA's Federal Federal Food food additive Food and Drug functions Government grivet hamsters hazards human industry infection influenza vaccine inoculated inspection laboratory legislation licensed lots manufacturers memorandum ment monkey kidney cell Morris Office oncogenic percent polio poliomyelitis poliovirus present problems product safety standard proposed protection Public Health recommendations regulation regulatory released responsibility rubella scientific scientists scrapie Secretary Richardson Senator PERCY Senator RIBICOFF sera serum studies Subcommittee sumer tion tissue titers tumors Turner vacuolating vacuolating virus virus vaccines viruses
Populāri fragmenti
103. lappuse - States a civil penalty of not more than $5,000 for each violation, which shall accrue to the United States and may be recovered in a civil action brought by the United States.
756. lappuse - Mount Sinai School of Medicine, City University of New York, New York, NY Dr.
872. lappuse - That no additive shall be deemed to be safe if it is found to induce cancer when ingested by man or animal, or if it is found, after tests which are appropriate for the evaluation of the safety of food additives, to induce cancer in man or animal...
445. lappuse - Formulary, or any supplement to any of them; and (2) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and (3) articles (other than food) intended to affect the structure or any function of the body of man or other animals...
49. lappuse - Administrator but not in excess of the maximum rate of pay for grade GS-18, as provided in the General Schedule under section 5332 of title...
875. lappuse - Any poisonous or deleterious substance added to any food, except where such substance is required in the production thereof or cannot be avoided by good manufacturing practice...
516. lappuse - There being no objection the memorandum was ordered to be printed in the RECORD, as follows: MEMORANDUM FOR THE HONORABLE ROBERT H.
877. lappuse - ... generally recognized, among experts qualified by scientific training and experience to evaluate its safety, as having been adequately shown through scientific procedures (or, in the case of a substance used in food prior to January 1, 1958.
256. lappuse - The oral contraceptives are powerful and effective drugs which can cause side effects in some users and should not be used at all by some women.
256. lappuse - By 1976 the Committee on Perinatal Health— a joint effort of the American Medical Association, the American College of Obstetricians and Gynecologists, the American Academy of...